Polynovo logo

PNV - Polynovo Share Price

A$2.62 -0.0  -1.5%

Last Trade - 12:40am

Mid Cap
Market Cap £992.9m
Enterprise Value £992.0m
Revenue £12.5m
Position in Universe 217th / 1842
Unlock PNV Revenue
Relative Strength (%)
1m -33.1%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -34.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.14 3.47 3.76 5.99 13.7 22.2 36.5 66.7 +175.1%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, Polynovo Ltdrevenues increased 62% to A$22.2M. Net loss increased 31%to A$4.2M. Revenues reflect United States of Americasegment increase of 59% to A$18.7M, Australia & New Zealandsegment increase of 80% to A$2.8M. Higher net loss reflectsEmployee related expenses - Balancing va increase of 54% toA$13M (expense), Share-based payments (expense) increasefrom A$97K to A$2.1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for PNV
Graphical History


PNV Revenue Unlock PNV Revenue

Net Income

PNV Net Income Unlock PNV Revenue

Normalised EPS

PNV Normalised EPS Unlock PNV Revenue

PE Ratio Range

PNV PE Ratio Range Unlock PNV Revenue

Dividend Yield Range

PNV Dividend Yield Range Unlock PNV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
PNV EPS Forecasts Unlock PNV Revenue
Profile Summary

Polynovo Ltd is an Australia-based medical device company. The Company designs, develops and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology. Its development program covers Breast Sling, Hernia and Orthopedic application. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture novel medical devices designed to support tissue repair and which then bio reabsorb in a defined fashion in-situ to harmless by-products. It manufactures NovoSorb polymer devices with the ability to elute drugs, antimicrobials as well as be expressed in a variety of physical formats, including films, foam, coatings/sprays, fibers, plastic structures and biological carrier. Its NovoSorb Biodegradable Temporising Matrix (BTM) is used in a fully debrided clean surgical wound to physiologically close the wound.

Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated August 12, 1998
Public Since November 26, 1998
No. of Shareholders: 20,708
No. of Employees: 78
Sector Healthcare
Industry Biotechnology & Medical Research
Index S&P/ASX All Ordinaries , S&P/ASX 200 , S&P/ASX 300 , ASX Small Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 661,088,402
Free Float (0.0%)
Eligible for
PNV Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for PNV
Upcoming Events for PNV
Frequently Asked Questions for Polynovo
What is the Polynovo share price?

As of 12:40am, shares in Polynovo are trading at A$2.62, giving the company a market capitalisation of £992.9m. This share price information is delayed by 15 minutes.

How has the Polynovo share price performed this year?

Shares in Polynovo are currently trading at A$2.62 and the price has moved by 4.31% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Polynovo price has moved by 6.23% over the past year.

What are the analyst and broker recommendations for Polynovo?

Of the analysts with advisory recommendations for Polynovo, there are there are currently 1 "buy" , 2 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Polynovo is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Polynovo next release its financial results?

Polynovo is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Polynovo dividend yield?

Polynovo does not currently pay a dividend.

Does Polynovo pay a dividend?

Polynovo does not currently pay a dividend.

When does Polynovo next pay dividends?

Polynovo does not currently pay a dividend.

How do I buy Polynovo shares?

To buy shares in Polynovo you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Polynovo?

Shares in Polynovo are currently trading at A$2.62, giving the company a market capitalisation of £992.9m.

Where are Polynovo shares listed? Where are Polynovo shares listed?

Here are the trading details for Polynovo:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: PNV
What kind of share is Polynovo?

Based on an overall assessment of its quality, value and momentum, Polynovo is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Polynovo share price forecast 2021?

Shares in Polynovo are currently priced at A$2.62. At that level they are trading at 12.44% discount to the analyst consensus target price of 0.00.

Analysts covering Polynovo currently have a consensus Earnings Per Share (EPS) forecast of -0.003 for the next financial year.

How can I tell whether the Polynovo share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Polynovo. Over the past six months, the relative strength of its shares against the market has been 4.47%. At the current price of A$2.62, shares in Polynovo are trading at 2.07% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Polynovo PE Ratio?

We were not able to find PE ratio data for Polynovo.

Who are the key directors of Polynovo?

Polynovo's management team is headed by:

David Williams - NEC
Robert Johnston - NID
Paul Brennan - CEO
Leon Hoare - NED
Jan Gielen - CFO
Ashok Srinivasan - COO
Robyn Elliott - NED
Christine Emmanuel - NED
Who are the major shareholders of Polynovo?

Here are the top five shareholders of Polynovo based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 5.03% (33.2m shares)
Williams (David John) Individual Investor
Percentage owned: 2.8% (18.5m shares)
Fidelity Funds - Pacific Fund Mutual Fund
Percentage owned: 1.66% (11.0m shares)
Fidelity International Investment Advisor
Percentage owned: 1.66% (11.0m shares)
Lateral Innovations Pty. Ltd. Corporation
Percentage owned: 1.65% (10.9m shares)
Similar to PNV
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.